| 1 | Gobind Kumar, Sahil Mishra, Pule Seboletswe, Neha Manhas, Safiyah Ghumran, Françoise Roquet-Banères, Laurent Kremer, Gaurav Bhargava, Parvesh Singh | Isoniazid-Rhodanine Molecular Hybrids: Design, Synthesis, Antimycobacterial Activity and Computational Validation | RSC Advances, 2025, 15, 31272 |
| 2 | Mukanda Gedeon Kadima, Sahil Mishra, Gobind Kumar, Pule Seboletswe, Afsana Kajee, Ankit, Françoise Roquet-Banères, Maëlle Foubert, Laurent Kremer, Rajshekhar Karpoormath, Parvesh Singh | Rational Design and Antimycobacterial Evaluation of Aryl Sulfonamide–Linked Isoniazid Hydrazones Against Mycobacterium tuberculosis | ChemMedChem, 2025, In press |
| 3 | Mukanda Gedeon Kadima, Sahil Mishra, Gobind Kumar, Pule Seboletswe, Françoise Roquet-Banères, Maëlle Foubert, Laurent Kremer, Rajshekhar Karpoormath, Parvesh Singh | Rationally designed InhA inhibitors: A comparative anti-tubercular activity study of sulfonate esters of Isoniazid hydrazones and their structurally flexible benzyl analogues | Chemical Biology and Drug Design, 2025, In press |
| 4 | Gobind Kumar, Pule Seboletswe, Sahil Mishra, Neha Manhas, Safiyah Ghumran, Nagaraju Kerru, Françoise Roquet‐Banères, Maëlle Foubert, Laurent Kremer, Gaurav Bhargava, Parvesh Singh | Isoniazid‐Dihydropyrimidinone Molecular Hybrids: Design, Synthesis, Antitubercular Activity, and Cytotoxicity Investigations with Computational Validation | ChemMedChem, 2025, 2400949. DOI |
| 5 | Baji Baba Shaik, Kimeshni Moodley, Safiyah Ghumran, Muhammad D Bala, Parvesh Singh, Rajshekhar Karpoormath | The Emerging Landscape of Tubercular Targets: A Medicinal Chemistry Approach | Medicinal Research Reviews, 2025, 45(4), 1077 |
| 6 | Pule Seboletswe, Gobind Kumar, Nontobeko Gcabashe, Sanjeev Dhawan, Neha Manhas, Lungisani Khubone, ALmahi Idris, Md. Shahidul Islam, Parvesh Singh | Antidiabetic evaluation of novel thienopyrimidinone-thiazolidinedione hybrids complemented with kinetic and computational investigations | Medicinal Chemistry Research, 2025, DOI |
| 7 | Sanjeev Dhawan, Ashona Singh, Neha Manhas, Pule Seboletswe, Lungisani Khubone, Gobind Kumar, Sreekantha B. Jonnalagadda, Asif Raza, Arun K. Sharma, Parvesh Singh | Exploring Novel Coumarin-Tethered Bis-Triazoles: Apoptosis Induction in Human Pancreatic Cancer Cells, Antimicrobial Effects, and Molecular Modelling Investigations | ChemMedChem, 2024, 19(22), e202400297 |
| 8 | Nontobeko Gcabashe, Gobind Kumar, Pule Seboletswe, Neha Manhas, Parvesh Singh | A rapid, greener and sustainable synthesis of N-acyl hydrazones of isoniazid in a deep eutectic solvent | Synlett, 2024, DOI: 10.1055/a-2417-1127 |
| 9 | Pule Seboletswe, Nosipho Cele, Parvesh Singh | Thiazolidinone-heterocycle framework: A concise review of their Pharmacological significance | ChemMedChem, 2023, 18(7), e202200618 |
| 10 | Neha Manhas, Parvesh Singh, Ashona Singh-Pillay, Neil Koorbanally | Synthesis, antibacterial screening and computational studies of quinazoline-4(3H)-one-triazole conjugates | Journal of Molecular Structure, 2023, 1292, 136108 |
| 11 | Nosipho Cele, Paul Awolade, Pule Seboletswe, Kolawole Olofinsan, Md. Shahidul Islam, Parvesh Singh | α-Glucosidase and α-amylase inhibitory potentials of quinoline–1,3,4-oxadiazole conjugates bearing 1,2,3-triazole with antioxidant activity, kinetic studies, and computational validation | Pharmaceuticals, 2022, 15(8), 1035 |
| 12 | Lalitha Gummidi, Nagaraju Kerru, Oluwakemi Ebenezer, Paul Awolade, Olakunle Sanni, Md. Shahidul Islam, Parvesh Singh | Multicomponent reaction for the synthesis of new 1,3,4-thiadiazole-thiazolidine-4-one molecular hybrids as promising antidiabetic agents through α-glucosidase and α-amylase inhibition | Bioorganic Chemistry, 2021, 115, 105210 |
